Literature DB >> 12930137

Structure-based design of a macrocyclic inhibitor for peptide deformylase.

Xubo Hu1, Kiet T Nguyen, Christophe L M J Verlinde, Wim G J Hol, Dehua Pei.   

Abstract

A macrocyclic, peptidomimetic inhibitor of peptide deformylase was designed by covalently cross-linking the P1' and P3' side chains. The macrocycle, which contains an N-formylhydroxylamine side chain as the metal-chelating group, was synthesized from a diene precursor via olefin metathesis using Grubbs's catalyst. The cyclic inhibitor showed potent inhibitory activity toward Escherichia coli deformylase (K(I) = 0.67 nM) and antibacterial activity against both Gram-positive and Gram-negative bacteria (MIC = 0.7-12 microg/mL).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12930137     DOI: 10.1021/jm034113f

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

1.  Design and synthesis of macrocyclic peptidyl hydroxamates as peptide deformylase inhibitors.

Authors:  Gang Shen; Jinge Zhu; Anthony M Simpson; Dehua Pei
Journal:  Bioorg Med Chem Lett       Date:  2007-12-10       Impact factor: 2.823

2.  Insights from ligand and structure based methods in virtual screening of selective Ni-peptide deformylase inhibitors.

Authors:  Ravi Shekar Ananthula; Muttineni Ravikumar; S K Mahmood; M N S Pavan Kumar
Journal:  J Mol Model       Date:  2011-05-12       Impact factor: 1.810

3.  Structure of the complex of porcine pancreatic elastase with a trimacrocyclic peptide inhibitor FR901451.

Authors:  Takayoshi Kinoshita; Tomoya Kitatani; Masaichi Warizaya; Toshiji Tada
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-08-31

4.  Drug forecast - the peptide deformylase inhibitors as antibacterial agents.

Authors:  David R P Guay
Journal:  Ther Clin Risk Manag       Date:  2007-08       Impact factor: 2.423

Review 5.  Structural and pharmacological effects of ring-closing metathesis in peptides.

Authors:  Øyvind Jacobsen; Jo Klaveness; Pål Rongved
Journal:  Molecules       Date:  2010-09-21       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.